GB0804326D0 - Novel compounds - Google Patents
Novel compoundsInfo
- Publication number
- GB0804326D0 GB0804326D0 GBGB0804326.7A GB0804326A GB0804326D0 GB 0804326 D0 GB0804326 D0 GB 0804326D0 GB 0804326 A GB0804326 A GB 0804326A GB 0804326 D0 GB0804326 D0 GB 0804326D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- novel compounds
- novel
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0804326.7A GB0804326D0 (en) | 2008-03-07 | 2008-03-07 | Novel compounds |
| PCT/EP2009/052567 WO2009109608A1 (en) | 2008-03-07 | 2009-03-05 | Novel compounds |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0804326.7A GB0804326D0 (en) | 2008-03-07 | 2008-03-07 | Novel compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0804326D0 true GB0804326D0 (en) | 2008-04-16 |
Family
ID=39327761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0804326.7A Pending GB0804326D0 (en) | 2008-03-07 | 2008-03-07 | Novel compounds |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB0804326D0 (en) |
| WO (1) | WO2009109608A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020048828A1 (en) | 2018-09-03 | 2020-03-12 | Bayer Pharma Aktiengesellschaft | 5-heteroaryl-3,9-diazaspiro[5.5]undecane compounds |
| TW202024083A (en) | 2018-09-03 | 2020-07-01 | 德商拜耳廠股份有限公司 | 3,9-diazaspiro[5.5]undecane compounds |
| CN113219094A (en) * | 2021-05-07 | 2021-08-06 | 湖北欣泽霏药业有限公司 | Liquid chromatography detection method for optical isomer of tomoxetine hydrochloride oral solution |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992006079A1 (en) * | 1990-09-28 | 1992-04-16 | Pfizer Inc. | Fused ring analogs of nitrogen containing nonaromatic heterocycles |
| AU2006275870B2 (en) * | 2005-07-27 | 2013-01-10 | Otsuka America Pharmaceutical, Inc. | Novel 1-aryl-3-azabicyclo[3.1.0]hexanes: preparation and use to treat neuropsychiatric disorders |
| EP2064186A1 (en) * | 2006-09-11 | 2009-06-03 | Glaxo Group Limited | Azabicyclic compounds as inhibitors of monoamines reuptake |
| GB0617867D0 (en) * | 2006-09-11 | 2006-10-18 | Glaxo Group Ltd | Chemical compounds |
-
2008
- 2008-03-07 GB GBGB0804326.7A patent/GB0804326D0/en active Pending
-
2009
- 2009-03-05 WO PCT/EP2009/052567 patent/WO2009109608A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009109608A1 (en) | 2009-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0823467D0 (en) | Novel Compounds | |
| GB0806536D0 (en) | Novel compounds | |
| GB0800035D0 (en) | Compounds | |
| GB0813142D0 (en) | Novel compounds | |
| GB0811587D0 (en) | Novel Compounds | |
| GB0808747D0 (en) | Novel compounds | |
| IL212799A0 (en) | Novel compounds | |
| GB0812849D0 (en) | Novel compounds | |
| GB0804592D0 (en) | Novel compounds | |
| GB0810228D0 (en) | Novel compounds | |
| GB0810981D0 (en) | Novel compounds | |
| IL213032A0 (en) | Novel compounds | |
| GB0813144D0 (en) | Novel compounds | |
| GB0808030D0 (en) | Novel compounds | |
| GB0804326D0 (en) | Novel compounds | |
| GB0800411D0 (en) | Novel compounds | |
| GB0809479D0 (en) | Novel compounds | |
| GB0805272D0 (en) | Novel compounds | |
| GB0805047D0 (en) | Novel compounds | |
| GB0802677D0 (en) | Novel compounds | |
| GB0802008D0 (en) | Novel compounds | |
| GB0801327D0 (en) | Novel compounds | |
| GB0800839D0 (en) | Novel compounds | |
| GB0800679D0 (en) | Novel compounds | |
| GB0803306D0 (en) | Novel compounds |